LloydsPharmacy parent company Celesio UK's managing director Cormac Tobin is stepping down with immediate effect, the multiple has announced.

Mr Tobin has been with the company for more than a decade, and was appointed its managing director in 2013. Celesio UK is currently looking for his successor, the company announced today (2 November).

In the meantime, the company will be headed up by the remaining members of the Celesio UK management board, who will report to Brian Tyler, chairman of the McKesson Europe's management board.

LloydsPharmacy made headlines last week after it announced that it would close 190 of its branches due to funding cuts and other financial clawbacks.

'Energetic and trusted leader'

Responding to the news, Mr Tyler said: 'Cormac has been an energetic and trusted leader of our UK and Ireland businesses.  He has built a strong leadership team for Celesio UK and his warm and engaging personality made him many friends across community pharmacy and beyond.

'There is a genuine affection for him amongst our colleagues who value his ability to understand customers and patients and put them at the heart of everything we do.

'I am grateful for the dedication that Cormac has shown over the last few years and his leadership through an ever-changing external environment. I wish him every success for the future.'

He continued: 'There is a strong and experienced management team in the UK consisting of Nigel Swift, Hilary Stables, Ruth Poole, Catherine McDermott and Marcus Hilger. Together with the entire business in the UK, this leadership team will be able to successfully navigate current and future challenges that the company faces.'

More on LloydsPharmacy:

190 LloydsPharmacy branches to close

Opinion: Even the multiples haven’t managed to dodge the brutal effects of the cuts